Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Are we too cavalier about antiviral prophylaxis?

Onwudiwe OC, Marmur ES, Cohen JL.

J Drugs Dermatol. 2013 Feb;12(2):199-205. Review.

PMID:
23377394
2.

Herpes simplex virus infection.

Whitley RJ.

Semin Pediatr Infect Dis. 2002 Jan;13(1):6-11. Review.

PMID:
12118847
3.

Herpes simplex virus latency and nucleoside analogues.

Efstathiou S, Field HJ, Griffiths PD, Kern ER, Sacks SL, Sawtell NM, Stanberry LR.

Antiviral Res. 1999 Apr;41(3):85-100. Review. No abstract available.

PMID:
10320042
4.

Famciclovir prophylaxis of herpes simplex virus reactivation after laser skin resurfacing.

Alster TS, Nanni CA.

Dermatol Surg. 1999 Mar;25(3):242-6.

PMID:
10193975
6.

Genotypic and phenotypic characterization of acyclovir-resistant herpes simplex viruses isolated from haematopoietic stem cell transplant recipients.

Stránská R, van Loon AM, Polman M, Beersma MF, Bredius RG, Lankester AC, Meijer E, Schuurman R.

Antivir Ther. 2004 Aug;9(4):565-75.

PMID:
15456088
7.

[Prevention of facial herpetic infections after chemical peel and dermabrasion: new treatment strategies in the prophylaxis of patients undergoing procedures of the perioral area].

Angel S, Boineau-Géniaux D, Salag P, Trepsat F, Chosidow O, Perrot JL, Will F, Grognard C.

Ann Dermatol Venereol. 1998 Jan;125(1):74-7. French. No abstract available.

PMID:
9747218
8.
9.

Herpes simplex virus in immunocompromised patients: growing evidence of drug resistance.

Epstein JB, Scully C.

Oral Surg Oral Med Oral Pathol. 1991 Jul;72(1):47-50. Review.

PMID:
1653925
10.

Treatment of acyclovir-resistant herpes simplex and varicella zoster virus infections.

Safrin S.

Adv Exp Med Biol. 1996;394:59-66. Review. No abstract available.

PMID:
8815710
11.
13.

Changes in plasma human immunodeficiency virus type 1 RNA associated with herpes simplex virus reactivation and suppression.

Schacker T, Zeh J, Hu H, Shaughnessy M, Corey L.

J Infect Dis. 2002 Dec 15;186(12):1718-25. Epub 2002 Nov 22.

14.

Disease and latency characteristics of clinical herpes virus isolated after acyclovir therapy.

Sibrack CD, McLaren C, Barry DW.

Am J Med. 1982 Jul 20;73(1A):372-5.

PMID:
6285725
15.

Interventions for the prevention and treatment of herpes simplex virus in patients being treated for cancer.

Glenny AM, Fernandez Mauleffinch LM, Pavitt S, Walsh T.

Cochrane Database Syst Rev. 2009 Jan 21;(1):CD006706. doi: 10.1002/14651858.CD006706.pub2. Review.

PMID:
19160295
16.

Empiric acyclovir for neonatal herpes simplex virus infection.

Vanderpluym C, Tawfik G, Hervas-Malo M, Lacaze-Masmonteil T, Kellner J, Robinson JL.

J Matern Fetal Neonatal Med. 2012 Aug;25(8):1278-82. doi: 10.3109/14767058.2011.629249. Epub 2011 Nov 10.

PMID:
21992471
17.

Famciclovir/penciclovir.

Sacks SL, Wilson B.

Adv Exp Med Biol. 1999;458:135-47. Review. No abstract available.

PMID:
10549386
18.

Herpes simplex virus resistance to acyclovir and penciclovir after two decades of antiviral therapy.

Bacon TH, Levin MJ, Leary JJ, Sarisky RT, Sutton D.

Clin Microbiol Rev. 2003 Jan;16(1):114-28. Review.

19.

Herpes simplex virus hepatitis 4 years after liver transplantation.

Bissig KD, Zimmermann A, Bernasch D, Furrer H, Dufour JF.

J Gastroenterol. 2003;38(10):1005-8.

PMID:
14614611
20.

Acyclovir prophylaxis to prevent herpes simplex virus recurrence at delivery: a systematic review.

Sheffield JS, Hollier LM, Hill JB, Stuart GS, Wendel GD.

Obstet Gynecol. 2003 Dec;102(6):1396-403. Review.

PMID:
14662233
Items per page

Supplemental Content

Write to the Help Desk